Literature DB >> 3100666

Effects of interferons-alpha, -beta, and -gamma on human interleukin-2 production.

I Rosztóczy, O Siroki, I Béládi.   

Abstract

Interleukin-2 (IL-2) production was stimulated with staphylococcus enterotoxin A, heat-killed Staphylococcus aureus, or concanavalin A (ConA) in cultures of human peripheral blood mononuclear cells (PBMC). IL-2 was characterized by its effect on IL-2-dependent cytotoxic T lymphocytes (CTLL cells) and mouse thymocytes. Pretreatment of PBMC with greater than or equal to 100 IU/ml of human-alpha (HuIFN-alpha) or interferon-beta (HuIFN-beta), or with greater than or equal to 10 IU/ml HuIFN-gamma for 4 h enhanced the IL-2 production. The effects of 20-h IFN treatments were less pronounced or they exerted an inhibitory effect. Our results indicate that IFNs modulate IL-2 production, which in turn can mediate some of the immunomodulatory effects of IFNs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100666     DOI: 10.1089/jir.1986.6.581

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  4 in total

Review 1.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.

Authors:  B Brooks; R C Rees
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Purification and characterization of the human interferon-gamma receptor from placenta.

Authors:  J Calderon; K C Sheehan; C Chance; M L Thomas; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  Natural killer (NK) activity of porcine blood lymphocytes against allogeneic melanoma target cells.

Authors:  M Büttner; R Wanke; B Obermann
Journal:  Vet Immunol Immunopathol       Date:  1991-08       Impact factor: 2.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.